Transcript
Page 1: Practical Approaches to Tumor Xenograft Analysis

Practical Approaches to Tumor Xenograft Analysis

Frank Voelker, Flagship Biosciences LLC

Trevor Johnson, Flagship Biosciences LLC

Veronica Traviglone, Infinity Pharmaceuticals

Igor Deyneko, Infinity Pharmaceuticals

Page 2: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Outline

Introduction

Anatomy of a Xenograft

Defining the Approach to the Analysis

Analytical Strategies

Examples of Cases

Presenting FACTS for Target Tissue Analysis

Page 3: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

General Anatomy of a Xenograft

CD-31 Stain for Microvessels

Page 4: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Chronic Inflammation and Peripheral Adipose Tissue

Adjacent tissue frequently contains host responses such as inflammation, adipose tissue or adnexal structures that need to be excluded from the analysis

Page 5: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Extensive Necrosis and Degeneration

Necrosis and neoplastic cells in various stages of degeneration are common features of a xenograft.

CD31 Immunostain

Page 6: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Host Response of Vascular Ingrowth Demonstrated with CD31 Immunostain

Even the smallest microvessels may be enclosed in adventitial tissue as an extension of stromal ingrowths

Page 7: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Compare H&E and IHC Stains

H&E

CD31

Page 8: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Compare Corresponding Areas of H&E and CD31 Stains

Compare microscopic characteristics of an H&E- stained section with comparable regions of an IHC CD31-stained section

This will provide valuable perspective regarding IHC target tissue staining and will allow more accurate identification of tissue classes.

H&E CD31

Page 9: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Significant Xenograft Tissue Components

Neoplastic CellsTissue BiomarkerConnective Tissue StromaNecrosis and DegenerationCystic or Secretory Vacuoles Artifactual Space

Which of these do you want to include in your analysis?

Page 10: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Some Examples of Analytical Endpoints

Neoplastic Cell AreaTotal Xenograft Area

Marker Area or Score Neoplastic Cell Area

A function of neoplastic cell abundance versus necrosis and/or stromal prominence

Immunohistochemistry expression of marker metabolism within neoplastic cell population

Number of Neoplastic NucleiNeoplastic Cell Area

An indication of mean neoplastic cell size

Targeted Cell NumberTotal Xenograft Area

Cell frequency within measured area

Number of MicrovesselsNeoplastic Cell + Stromal Area

Microvessel analysis

Page 11: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

What aspects of a marker determine treatment effect?

(Nwp/Ntotal)x(100) + Np/Ntotal)x(200) + Nsp/Ntotal)x(300) = “H Score” (For a maximum of 300)

Staining variation in tumors or other tissues frequently raises the question of whether to measure either percent area or average intensity of an immunostain.

In some cases, a solution to this problem is to measure score as an output convention encompassing both percent area and stain intensity.

Page 12: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com12

Manual Use of Positive and Negative Pen Tools

Similar IHC staining of fibronectin and secretion droplets in this xenograft tumor with subsequent poor differentiation by the Genie™ classifier required the use of the negative pen tool to assist in quantitating fibronectin using the IHC deconvolution algorithm.

Page 13: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Manual Use of Positive and Negative Pen Tools

Use of a 21UX Cintiq Wacom drawing board facilitates the use of positive and negative pen tools in manually delineating critical features of the xenograft.

Page 14: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Using Genie™ to Segregate Neoplasm from Nontarget Tissue in a Xenograft Stained for Phospho-Histone 3

Central regions of the xenograft contain an interdigitating pattern of necrosis and connective tissue trabeculae too complex for manual exclusion .

Accurate segregation of neoplasm (green) from necrosis and connective tissue (red) was accomplished using Genie™

Page 15: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

The Rationale Behind Histology Feature Recognition

Using software to preprocess an image with the purpose of segregating target tissue components from nontarget tissue.

Aperio Genie™

Visiopharm

Subsequent analysis yields accurate data only from the target tissue component, and omits erroneous nonspecific results from nontarget tissue.

Feature recognition is valuable in xenograft analysis when target and nontarget regions are too intricately interwoven for manual exclusion.

Page 16: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Strategy for Analyzing Successive Samples

Progression of analysis through sample series

Red = 1st ClassifierBlue = 2nd ClassifierGreen = 3rd Classifier* = Points when a new classifier was developed during the analysis

***

Xenograft neoplasms within a study are surprisingly heterogeneous even though derived from the same source, and it is difficult and time consuming to derive a common pattern recognition classifier appropriate for all neoplasms within a study. It is more expeditious and also yields more accuracy to develop new classifiers as the analysis progresses.

Page 17: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Consistent Analysis of Study Samples Using Genie™

Subsequent Uniform Analysis of Segregated Target Tissue for area/intensity

Even though multiple classifiers are constructed for successive samples, the final analyses of target tissue components will be accurate and comparable if

the same algorithm threshold values are constantly maintained.

Page 18: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Using Genie™ to Segregate Neoplasm from Nontarget Tissue in a Xenograft Stained for Phospho-Histone 3

Higher magnification reveals accurate separation of target from nontarget tissue.

The grayed-out nontarget tissue class consists of a mixture of connective tissue trabeculae and necrotic tumor cells.

Page 19: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Assessing Fibronectin in a Xenograft Using Several Software Programs

Assessing the intensity and quantity of fibronectin as a marker in xenograft stroma

Aperio Deconvolution Mark-up

Visiopharm Mark-up

Original IHC Image

Page 20: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com20

Assessing Angiogenesis in a Xenograft Using Several Software Programs

Use of the microvessel analysis algorithm to assess angiogenesis in a xenograft neoplasm in a mouse

Microvessel analysis provides important information regarding potential antineoplastic effects of pharmaceutical compounds

Original CD31-Stained Image

Aperio Microvessel Algorithm Mark-up

Visiopharm Mark-up

Page 21: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Using the Microvessel Analysis Algorithm to Count Cyclin B1-Positive Target Cells in a Xenograft

Use of the microvessel analysis algorithm to assess macrophage populations in mouse xenograft neoplasms

Threshold algorithm parameters are modified to accommodate the smaller size and shape characteristics of the cells

Page 22: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Use of Visiopharm™ Software to Analyze a Marker Separately in Cytoplasm and Nuclei of a Neoplasm

Discriminating between nuclear and cytoplasmic regions of a neoplasm allows separate biomarker intensity measurement for both nuclear and cytoplasmic markers (analysis with Visiopharm software).

Page 23: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Distinctive or Special Staining Facilitates Target Tissue Pattern Recognition

H&E H&E Classifier

CD31 CD31 Classifier

First pass accuracy is much greater for the H&E-stained section than for the hematoxylin- counterstained IHC section

Current histology pattern recognition programs often have difficulty distinguishing target tissue profiles because of low contrast /nonspecific counterstaining

Page 24: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Feature Analysis on Consecutive Tissue Sections (FACTS)

4. QC and pathologist

review

3. Image and ROI

registration

2. Automatedfeature

recognition

1. Consecutive tissue

sectioning

Page 25: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Image and ROI Registration

Register images with <3% Feature Error Across multiple consecutive slides– Not a trivial problem given the potential histological and

biological differences between tissue sections and stains

Several registration techniques currently used throughout CT/MRI, CT/PET, CT radiology, ultrasound, and multispectral imaging– Typically elastic, morphing, because of image warping– Heavy use of image features or fiducials

Type of registration for best performance in FFPE tissue is heavily dependent on the application

3. Image and ROI

registration

Page 26: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Typical Image Registration Process

Feature detection

– Distinctive objects to be aligned

Feature matching

– Finding the association between the distinct objects

Transform model estimation

– The mapping functions used to align the subsequent image to the reference image

– May be non-elastic (much simpler) or elastic

Image re-sampling and transformation

– Applying the mapping functions where non-integer coordinates can be correctly interpolated

Page 27: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Non-Elastic Image to Image Registration

Perform color deconvolution to focus on a common Stain, typically Hematoxylin

– Helps reduce potential errors from strongly stained “positive” features

Use slide features and image intensities to adjust rotation and translation of selected images or regions

u(x,y) -> v(x,y)

Rotation: x’ = x•cos(θ) - y•sin(θ)

y’ = x•sin(θ) + y•cos(θ)

Translation: x -> x’

y -> y’

Page 28: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Example of Slide Registration

Page 29: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Annotated Feature to Feature Registration

More complex due to biological and histological differences between serial sections

Usually Elastic to count for these differences

– Important to note that the actual images are never morphed, just the annotations

Let the application determine the method

Phase Registration:

℮xp(2 ∏ i (u x’ + v y’)) = ƒ(f) ƒ(g) / | ƒ(f) ƒ(g) |

Mutual Information:

MI(X,Y) = H(Y) – H(Y | X) = H(X) – H(Y) – H(X,Y)

where H(X) = Ex(log(P(X))

Page 30: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Wavelet Transform:

Decompose image into collection of appropriate wavelet (Spline, Haar, Etc.)

Filter image along rows and columns (high and low pass)

Find frequency coefficients and apply differential measurements

Annotation Feature to Feature Registration (cont.)

Page 31: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Example of Feature Registration

Page 32: Practical Approaches to Tumor Xenograft Analysis

www.flagshipbio.com

Acknowledgments

Dr. Steven Potts, Flagship Biosciences LLC

Dr. David Young, Flagship Biosciences LLC

Ms. Charlotte Aagaard Johnson, Visiopharm Inc.

Mr. Rob Diller, Flagship Biosciences LLC

Mr Erik Hagendorn, Flagship Biosciences LLC

Questions? Email contact: [email protected]

[email protected]


Recommended